Find Paid Clinical Trials in Alabama

Paid Clinical Trials and Focus Groups

Find Paid Clinical Trials

Paid Clinical Trials in Alabama

Top of Directory » All Locations » United States » Alabama




  • A Phase IIb 78-week Study in Patients on a Basal Insulin +/- Metformin and/or Sulfonylurea and Are Not at Goal to Add BI 10773 vs. Placebo

    Condition:   Diabetes Mellitus, Type 2
    Intervention:   Drug: BI 10773
    Sponsor:   Boehringer Ingelheim Pharmaceuticals
    Recruiting - verified November 2009

  • A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

    Condition:   Pulmonary Disease, Chronic Obstructive
    Interventions:   Drug: GW642444 Inhalation Powder;   Drug: FF/GW642444 Inhalation Powder
    Sponsor:   GlaxoSmithKline
    Recruiting - verified November 2009

  • Voice and Swallowing Outcomes Following Revision Anterior Cervical Spine Surgery

    Conditions:   Dysphagia;   Dysphonia
    Intervention:   Other: Voice and Swallowing evaluations
    Sponsor:   University of Alabama at Birmingham
    Recruiting - verified November 2009

  • Staples Versus Suture for Cesarean Wound Closure

    Condition:   Wound
    Interventions:   Device: Surgical staples;   Device: Absorbable Surgical Suture
    Sponsor:   University of Alabama at Birmingham
    Recruiting - verified November 2009

  • Identification of the Pericardiophrenic Vein During Cardiac Device Implant Procedures to Prevent Extracardiac Stimulation

    Condition:   Heart Failure
    Intervention:  
    Sponsor:   Cardiac Concepts, Inc.
    Recruiting - verified November 2009

  • Efficacy and Safety of Budesonide Foam for Patients With Active Mild to Moderate Ulcerative Proctitis or Proctosigmoiditis

    Conditions:   Proctitis;   Proctosigmoiditis
    Interventions:   Drug: Budesonide;   Drug: Placebo
    Sponsor:   Salix Pharmaceuticals
    Not yet recruiting - verified November 2009

  • A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis

    Condition:   Rheumatoid Arthritis
    Interventions:   Drug: tocilizumab;   Drug: tocilizumab;   Drug: methotrexate
    Sponsor:   Hoffmann-La Roche
    Recruiting - verified November 2009

  • Bilateral Oophorectomy Versus Ovarian Conservation

    Conditions:   Oophorectomy;   Hysterectomy
    Interventions:   Procedure: Bilateral salpingo-oophorectomy;   Procedure: Ovarian conservation
    Sponsors:   University of California, San Francisco;   University of Alabama at Birmingham
    Recruiting - verified November 2009

  • Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis

    Condition:   Onychomycosis
    Interventions:   Drug: IDP-108;   Drug: Vehicle
    Sponsor:   Dow Pharmaceutical Sciences
    Not yet recruiting - verified November 2009

  • The Ventricular Catheter Placement Study: Assessment of Efficacy and Safety of an Ultrasound Guided Shunt Insertion Technique

    Condition:   Pediatric Hydrocephalus
    Intervention:  
    Sponsor:   University of Utah
    Recruiting - verified November 2009

  • Study of A3309 in Patients With Chronic Idiopathic Constipation

    Conditions:   Constipation;   Chronic Constipation
    Intervention:   Drug: A3309
    Sponsor:   Albireo
    Recruiting - verified November 2009

  • Stereotactic Radiation Therapy and Sorafenib in the Treatment of Hepatocellular Carcinoma

    Conditions:   Hepatocellular Carcinoma;   Liver Cancer
    Interventions:   Drug: Sorafenib;   Radiation: Stereotactic Body Radiotherapy (SBRT)
    Sponsors:   University of Alabama at Birmingham;   Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma
    Not yet recruiting - verified November 2009

  • Collecting Information From Patients Enrolled in the Breast Specialized Program of Research Excellence

    Condition:   Breast Cancer
    Intervention:   Other: informational intervention
    Sponsors:   University of Alabama at Birmingham;   National Cancer Institute (NCI)
    Recruiting - verified October 2009

  • Study of Bone Marrow and Blood Samples in Patients With Untreated Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia Enrolled on Clinical Trial CALGB-9621 or CALGB-9720

    Condition:   Leukemia
    Intervention:   Other: laboratory biomarker analysis
    Sponsors:   Cancer and Leukemia Group B;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents for the Maintenance of Remission of Ulcerative Colitis

    Condition:   Ulcerative Colitis
    Interventions:   Drug: Asacol (mesalamine), High Dose;   Drug: Asacol (mesalamine), Low Dose
    Sponsor:   Procter and Gamble
    Recruiting - verified October 2009

  • Safety, Efficacy, and Pharmacokinetic Study of Intravenous Ibuprofen in Pediatric Patients

    Condition:   Fever
    Interventions:   Drug: ibuprofen;   Drug: acetaminophen
    Sponsor:   Cumberland Pharmaceuticals
    Not yet recruiting - verified October 2009

  • Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants

    Conditions:   Haemophilus Influenzae Type B Related Disease;   Pneumonia;   Meningitis;   Cellulitis;   Osteomyelitis;   Epiglottis
    Interventions:   Biological: GSK Biologicals' Haemophilus inluenzae type b vaccine (GSK 208108);   Biological: ActHIBTM;   Biological: PentacelTM;   Biological: PediarixTM;   Biological: PrevnarTM;   Biological: RotarixTM;   Biological: EngerixTM-B;   Biological: InfanrixTM
    Sponsor:   GlaxoSmithKline
    Not yet recruiting - verified November 2009

  • Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma

    Condition:   Lymphoma
    Intervention:   Other: biologic sample preservation procedure
    Sponsors:   Southwest Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • The Efficacy and Safety of Adding Methotrexate to Etanercept in Psoriasis

    Condition:   Psoriasis
    Interventions:   Drug: Methotrexate and Etanercept;   Drug: Etanercept ONLY
    Sponsors:   Amgen;   Immunex Corporation
    Not yet recruiting - verified November 2009

  • A Study to Evaluate the Efficacy and Safety of DR-103 for the Prevention of Pregnancy

    Condition:   Pregnancy Prevention
    Intervention:   Drug: DR-103
    Sponsor:   Teva Women's Health
    Recruiting - verified October 2009

  • Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers

    Conditions:   Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
    Interventions:   Genetic: cytogenetic analysis;   Genetic: fluorescence in situ hybridization
    Sponsors:   Southwest Oncology Group;   National Cancer Institute (NCI);   Eastern Cooperative Oncology Group
    Recruiting - verified November 2009

  • Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence

    Condition:   Female Stress Urinary Incontinence Due to Intrinsic Sphincter Deficiency
    Intervention:   Device: Coaptite®
    Sponsor:   BioForm Medical, Inc.
    Recruiting - verified November 2009

  • Efficacy and Safety Study of JTT-654 in Type 2 Diabetic Patients

    Condition:   Type II Diabetes Mellitus
    Interventions:   Drug: JTT-654;   Drug: JTT-654 Placebo
    Sponsor:   Akros Pharma Inc.
    Recruiting - verified November 2009

  • Safety and Efficacy of Once-Daily KRP-104 in Type 2 Diabetic Patients That Cannot Control Their Diabetes on Metformin Alone

    Condition:   Type 2 Diabetes
    Interventions:   Drug: KRP-104;   Drug: Placebo
    Sponsors:   ActivX Biosciences, Inc.;   Kyorin Pharmaceutical Co.,Ltd
    Recruiting - verified October 2009

  • Safety and Tolerability of TAK-491 Plus Chlorthalidone Compared to Olmesartan Medoxomil-Hydrochlorothiazide in Subjects With Essential Hypertension

    Condition:   Essential Hypertension
    Interventions:   Drug: TAK-491 and chlorthalidone;   Drug: Olmesartan medoxomil-hydrochlorothiazide
    Sponsor:   Takeda Global Research & Development Center, Inc.
    Recruiting - verified November 2009

  • The Use of Certolizumab Pegol in Adult Subjects With Rheumatoid Arthritis to Assess the Antibody Response When Receiving Influenza Virus and Pneumococcal Vaccines

    Condition:   Rheumatoid Arthritis
    Interventions:   Biological: Placebo;   Biological: Certolizumab pegol
    Sponsor:   UCB, Inc.
    Recruiting - verified November 2009

  • A Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy (HALT-HE)

    Conditions:   Cirrhosis;   Hepatic Encephalopathy
    Interventions:   Drug: HPN-100 (formerly known as GT4P);   Drug: HPN-100 Placebo
    Sponsor:   Hyperion Therapeutics, Inc.
    Recruiting - verified October 2009

  • Safety of and Immune Response to an H1N1 Influenza Virus Vaccine in HIV Infected Children and Youth

    Conditions:   HIV Infections;   H1N1 Influenza Virus
    Intervention:   Biological: Influenza A (H1N1) 2009 monovalent vaccine
    Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
    Not yet recruiting - verified October 2009

  • A Phase 3b Study of Vernakalant Injection in Patients With Recent Onset Symptomatic Atrial Fibrillation (AF)

    Condition:   Atrial Fibrillation
    Interventions:   Drug: Vernakalant;   Drug: Placebo
    Sponsors:   Astellas Pharma Inc;   Cardiome Pharma
    Recruiting - verified November 2009

  • A Multiple Ascending Dose Study of the mTOR Inhibitor (RAD001) in Combination With R1507 in Patients With Advanced Solid Tumors

    Condition:   Neoplasms
    Interventions:   Drug: R1507;   Drug: RAD001
    Sponsor:   Hoffmann-La Roche
    Recruiting - verified November 2009

  • A Study of YM155 Plus Rituximab in Subjects With Non-Hodgkin's Lymphoma Who Have Received Prior Treatment

    Condition:   Non-Hodgkin's Lymphoma
    Interventions:   Drug: YM155;   Biological: Rituximab
    Sponsor:   Astellas Pharma Inc
    Recruiting - verified November 2009

  • Safety and Immunogenicity of H1N1 Vaccines in Adults Aged 18 Years and Older

    Condition:   Influenza Infection
    Interventions:   Biological: GSK2340273A;   Biological: Saline placebo;   Biological: GSK2340274A
    Sponsor:   GlaxoSmithKline
    Recruiting - verified November 2009

  • Dapagliflozin DPPIV Inhibitor add-on Study

    Condition:   Type 2 Diabetes
    Interventions:   Drug: Dapagliflozin;   Drug: Placebo
    Sponsors:   AstraZeneca;   Bristol-Myers Squibb
    Recruiting - verified November 2009

  • An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants

    Condition:   Healthy
    Intervention:  
    Sponsor:   MedImmune LLC
    Recruiting - verified October 2009

  • Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Liver Cancer

    Condition:   Liver Cancer
    Interventions:   Drug: cisplatin;   Drug: doxorubicin hydrochloride;   Drug: fluorouracil;   Drug: irinotecan hydrochloride;   Drug: vincristine sulfate;   Procedure: liver transplantation;   Procedure: observation
    Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children

    Condition:   Influenza Infection
    Interventions:   Biological: GSK investigational vaccine GSK1557482A;   Biological: Fluzone®
    Sponsor:   GlaxoSmithKline
    Recruiting - verified November 2009

  • A Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin Glargine

    Condition:   Diabetes Mellitus, Type 2
    Interventions:   Drug: insulin glargine + preprandial lispro insulin;   Biological: albiglutide + insulin glargine
    Sponsor:   GlaxoSmithKline
    Recruiting - verified November 2009

  • Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne

    Condition:   Severe Nodular Acne
    Intervention:   Drug: CIP-Isotretinoin and Isotretinoin
    Sponsor:   Cipher Pharmaceuticals Inc.
    Recruiting - verified November 2009

  • A Study to Evaluate the Safety and Efficacy of Subcutaneously Administered REGN475 in Patients With Sciatic Pain

    Condition:   Sciatica
    Interventions:   Drug: REGN475;   Drug: REGN475;   Drug: Placebo Injection
    Sponsors:   Regeneron Pharmaceuticals;   Sanofi-Aventis
    Recruiting - verified November 2009

  • An Efficacy and Safety Study of Intravenous Golimumab in Patients With Active Rheumatoid Arthritis (RA) Despite Treatment With Methotrexate, Non Steroidal Pain Medications and/or Corticosteroids

    Condition:   Arthritis, Rheumatoid
    Interventions:   Biological: golimumab;   Biological: golimumab;   Biological: golimumab;   Drug: placebo
    Sponsors:   Centocor, Inc.;   Schering-Plough
    Recruiting - verified November 2009

  • A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Osteoarthritis-related Pain

    Conditions:   Osteoarthritis;   Osteoarthritis, Hip;   Osteoarthritis, Knee;   Pain;   Arthralgia;   Joint Pain
    Interventions:   Drug: JNJ-42160443;   Drug: Placebo;   Drug: JNJ-42160443;   Drug: JNJ-42160443;   Drug: JNJ-42160443;   Drug: JNJ-42160443
    Sponsor:   Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
    Recruiting - verified November 2009

  • A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Low Back Pain

    Conditions:   Low Back Pain;   Low Back Pain, Recurrent
    Interventions:   Drug: JNJ-42160443;   Drug: JNJ-42160443;   Drug: JNJ-42160443;   Drug: JNJ-42160443;   Drug: Placebo
    Sponsor:   Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
    Recruiting - verified November 2009

  • Efficacy and Safety of the Extracorporeal Liver Assist Device (ELAD) in Acute on Chronic Hepatitis (Stabilization in Liver Disease)

    Condition:   Acute On Chronic Hepatitis
    Interventions:   Device: Extracorporeal Liver Assist Device (ELAD);   Other: Standard of care
    Sponsor:   Vital Therapies, Inc.
    Recruiting - verified October 2009

  • Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) for the Treatment of Symptomatic Atrial Fibrillation

    Condition:   Paroxysmal Atrial Fibrillation
    Intervention:   Device: CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC)
    Sponsor:   CardioFocus
    Recruiting - verified October 2009

  • Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Pioglitazone

    Condition:   Diabetes Mellitus, Type II
    Interventions:   Drug: Placebo;   Drug: Dutogliptin
    Sponsors:   Forest Laboratories;   Phenomix
    Recruiting - verified November 2009

  • CANagliflozin Treatment And Trial Analysis-Sulfonylurea (CANTATA-SU) SGLT2 Add-on to Metformin Versus Glimepiride

    Condition:   Diabetes Mellitus, Type 2
    Interventions:   Drug: JNJ-28431754;   Drug: glimepiride
    Sponsor:   Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
    Recruiting - verified November 2009

  • A Study to Evaluate the Efficacy and Safety of Rontalizumab in Patients With Moderately to Severely Active Systemic Lupus Erythematosus

    Condition:   Systemic Lupus Erythematosus
    Interventions:   Drug: placebo;   Drug: rontalizumab
    Sponsor:   Genentech
    Recruiting - verified November 2009

  • Study of Blood Samples From Newborns With Down Syndrome

    Condition:   Leukemia
    Interventions:   Genetic: DNA analysis;   Genetic: RNA analysis;   Genetic: cytogenetic analysis;   Genetic: fluorescence in situ hybridization;   Genetic: gene expression analysis;   Genetic: microarray analysis;   Genetic: mutation analysis;   Genetic: polymerase chain reaction;   Genetic: polymorphism analysis;   Other: flow cytometry;   Other: laboratory biomarker analysis;   Other: pharmacological study
    Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • A Study to Evaluate the Safety and Effectiveness of Ustekinumab or Golimumab Administered Subcutaneously (SC) in Patients With Sarcoidosis

    Condition:   Sarcoidosis
    Interventions:   Drug: golimumab;   Drug: ustekinumab;   Drug: Placebo
    Sponsor:   Centocor, Inc.
    Recruiting - verified November 2009

  • Calorie Restriction and Changes in Body Composition, Disease, Function, and Quality of Life in Older Adults

    Conditions:   Blood Pressure;   Cardiometabolic Risk
    Intervention:   Behavioral: Exercise and Diet in Older Adults
    Sponsor:   University of Alabama at Birmingham
    Not yet recruiting - verified October 2009

    • Menu
    Find Paid Clinical Trials